Non insulin meds (copy)

This drug must be taken with the first bite of food to work effectively.

A-glucosidase inhibitors (Acarbose miglitol)

A-glucosidase inhibitors drug list?

Acarbose miglitol

This drug delays the absorption of complex carbs in the intestine and slows the entry of glucose into systemic circulation.

A-glucosidase inhibitors (Acarbose miglitol)

What side effects would you monitor for A-glucosidase inhibitors (Acarbose miglitol)?

Hypoglycemia

GI side effects

This drug inhibits production of glucose by the liver

Biguanides (Metformin)

Biguanides drugs list?

Metformin

Metformin with glyburide

Biguanides can cause?

Lactic acidosis

Acute kidney injury

What would you monitor for regarding Biguanides (Metformin)?

Lactic acidosis

Kidney function

Dipeptidyl peptidase-4 inhibitors all end with?

-liptin

Dipeptidyl peptidase-4 inhibitors side effects?

Hypoglycemia

Stuffy nose

Dipeptidyl peptidase-4 inhibitors are given how often?

Once a day

Sulfonylureas are avoided in what populations?

Older adults

Why are Dipeptidyl peptidase-4 inhibitors avoided in older populations?

It’s excreted through the kidneys and may worsen hypoglycemia side effects (if present)

When taken with beta-andrenergic blocking agents this may mask usual warning S/S of hypoglycemia.

Dipeptidyl peptidase-4 inhibitors

Meglitinides all end with?

-linide

Meglitinides should only be taken if the patient can?

Eat a meal immediately

These medications stimulate the pancreas to release insulin.

Sulfonylureas

Meglitinides

What medications can a Type 1 diabetic receive?

Only insulin and amylins

Amylin is a

Non-insulin injectable agent

Amylin drug list:

Pramlintide (Symlin)

What would you watch for regarding Amylins?

Severe Hypoglycemia

Incretin mimetic (GLP-1) drug list:

end with -lutide

like semaglutide (Ozempic)

Enhances glucose-dependent insulin secretion and exhibits other antihyperglycemic actions following their release into the circulation from the gastrointestinal tract.

Incretin mimetics

Incretin mimetics increase the risk of ?

Thyroid tumors